Antibiotic Developer Tetraphase Prices Initial Public Offering

Antibiotic drug developer Tetraphase Pharmaceuticals Inc., of Watertown, Mass., joined recent publicly listed antibiotic-focused biotechnology companies Trius Therapeutics Inc. (2010) and Cempra Inc. (2012) by pricing its initial public offering (IPO) Wednesday. The company also achieved its objective of raising $75 million.